Reckitt Benckiser Group/£RKT
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Reckitt Benckiser Group
- Ticker
- £RKT
- Sector
- Consumer Essentials
- Primary listing
- LSE
- Employees
- 36,200
- Headquarters
- Slough, United Kingdom
- Website
- www.reckitt.com
RKT Metrics
BasicAdvanced
£36B
12.77
£4.43
0.25
£4.51
7.98%
Price and volume
Market cap
£36B
Beta
0.25
52-week high
£65.14
52-week low
£36.64
Average daily volume
1.5M
Dividend rate
£4.51
Financial strength
Current ratio
0.592
Quick ratio
0.382
Long term debt to equity
1.325
Total debt to equity
1.797
Dividend payout ratio (TTM)
103.37%
Interest coverage (TTM)
7.08%
Profitability
EBITDA (TTM)
3,590
Gross margin (TTM)
59.57%
Net profit margin (TTM)
21.09%
Operating margin (TTM)
22.68%
Effective tax rate (TTM)
17.43%
Revenue per employee (TTM)
£380,000
Management effectiveness
Return on assets (TTM)
7.88%
Return on equity (TTM)
48.02%
Valuation
Price to earnings (TTM)
12.773
Price to revenue (TTM)
2.688
Price to book
6.33
Price to tangible book (TTM)
-3.52
Price to free cash flow (TTM)
11.502
Free cash flow yield (TTM)
8.69%
Free cash flow per share (TTM)
4.921
Dividend yield (TTM)
7.98%
Growth
Revenue change (TTM)
-2.49%
Earnings per share change (TTM)
136.18%
3-year revenue growth (CAGR)
-3.15%
10-year revenue growth (CAGR)
4.35%
3-year earnings per share growth (CAGR)
11.14%
10-year earnings per share growth (CAGR)
6.96%
3-year dividend per share growth (CAGR)
3.02%
10-year dividend per share growth (CAGR)
3.36%
What the Analysts think about RKT
Analyst ratings (Buy, Hold, Sell) for Reckitt Benckiser Group stock.
Analyst projections of the future price of Reckitt Benckiser Group stock.
Bulls say / Bears say
Emerging Markets delivered 8.0% like-for-like growth in Q3, or 9.8% excluding Russia Hygiene, while Europe returned to growth and Core Reckitt sales rose 3.3%. This broadening across markets gives the business growth support beyond any one region. (Reckitt)
Management expects the second-half adjusted operating margin to improve on the first half’s 23.6% and reiterated its 4%–5% medium-term Core Reckitt sales growth target. If cost savings and stronger mix deliver as planned, earnings could grow faster than sales. (Reckitt)
A unanimous federal jury verdict in Mead Johnson’s favour on key issues in the infant-formula litigation may reduce a major obstacle to selling the non-core business. A sale could help remove a longstanding source of uncertainty, although the verdict does not resolve all claims. (The Grocer)
Reckitt cut its 2026 Core like-for-like sales growth forecast to 3.5%–4.5% from 4%–5% after Q3 growth came in at 3.3%. That signals weaker near-term momentum and leaves less room for further setbacks. (Reckitt)
North American sales fell 1.3% as manufacturing constraints prevented Reckitt from meeting strong Lysol demand. Resolving the supply issues will take execution, while the company has also announced a multi-year US investment of up to $600 million. (Reckitt)
The infant-formula litigation remains an open-ended risk: Reckitt says a possible cash outflow may be significant and cannot currently be estimated reliably. Recent favourable verdicts therefore have not removed the potential liability. (Reckitt)
Data summarised monthly by Lightyear AI. Last updated on 27 Oct 2026.
RKT Financial Performance
Revenues and expenses
RKT Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing RKT
AllEURGBPUSD
Fund name | Fund size | £RKT weighting |
|---|---|---|
iShares STOXX Europe 600 Personal & Household Goods€EXH7 | €190M | 5.16% |
iShares Core FTSE 100£CUKX | £3.3B | 1.39% |
iShares Core FTSE 100£ISF | £16B | 1.39% |
iShares Core FTSE 100€ISFA | £16B | 1.39% |
Vanguard FTSE 100£VUKE | £4.7B | 1.26% |
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.